Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid–Resistant Nephrotic Syndrome - Büscher, Anja K.; Beck, Bodo B.; Melk, Anette; Hoefele, Julia; Kranz, Birgitta; Bamborschke, Daniel; Baig, Sabrina; Lange-Sperandio, Bärbel; Jungraithmayr, Theresa; Weber, Lutz T.; Kemper, Markus J.; Tönshoff, Burkhard; et al. (Clinical journal of the American Society of Nephrology, 2016)
Keywords: Adolescent; Austria; Biopsy; Child; Child, Preschool; Cross-Sectional Studies; Cyclosporine - adverse effects; Cyclosporine - therapeutic use; Disease Progression; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Germany; Humans; Immunosuppressive Agents - adverse effects; Immunosuppressive Agents - therapeutic use; Infant; Intracellular Signaling Peptides and Proteins - genetics; Kidney - drug effects; Kidney - pathology; Kidney - physiopathology; Kidney Failure, Chronic - diagnosis; Kidney Failure, Chronic - genetics; Longitudinal Studies; Male; Membrane Proteins - genetics; Mutation; Nephrotic Syndrome - congenital; Nephrotic Syndrome - diagnosis; Nephrotic Syndrome - drug therapy; Nephrotic Syndrome - genetics; Nephrotic Syndrome - physiopathology; Original; Phenotype; Recovery of Function; Remission Induction; Risk Factors; Time Factors; Treatment Outcome; WT1 Proteins - genetics; kidney failure, chronic; mutation; cyclosporine A; NPHS1; steroid resistant nephrotic syndrome; NPHS2; WT1; FSGS; humans